Cargando…
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM): A Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Reported Data from the BE RADIANT Phase 3b Trial
INTRODUCTION: This analysis assessed the psychometric properties of the Psoriasis Symptoms and Impacts Measure (P-SIM), a novel patient-reported outcome (PRO) tool designed to capture patient experiences of the signs, symptoms and impacts of psoriasis. METHODS: Blinded data from the BE RADIANT phase...
Autores principales: | Gottlieb, Alice B., Warren, Richard B., Augustin, Matthias, Garcia, Llenalia, Cioffi, Christopher, Peterson, Luke, Pelligra, Christopher, Ciaravino, Valerie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478739/ https://www.ncbi.nlm.nih.gov/pubmed/34471992 http://dx.doi.org/10.1007/s12325-021-01836-1 |
Ejemplares similares
-
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM), a Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Data from the BE VIVID and BE READY Phase 3 Trials
por: Warren, Richard B., et al.
Publicado: (2021) -
Development and Content Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM) for Assessment of Plaque Psoriasis
por: Gottlieb, Alice B., et al.
Publicado: (2020) -
Guselkumab for plaque psoriasis
Publicado: (2019) -
Bimekizumab for plaque psoriasis
Publicado: (2022) -
Apremilast in the Treatment of Plaque Psoriasis: Differential Use in Psoriasis
por: Gao, Jia C, et al.
Publicado: (2022)